Catalent Expands Singapore Clinical Supply Facility

Site celebrates 20th anniversary by adding GMP space for secondary packaging, doubling ambient storage, and quadrupling cold storage capacity.

Catalent Pharma Solutions, a global provider of advanced delivery technologies and development offerings for drugs, biologics and consumer health products, completed a two-year, $4.6 million expansion at its Singapore clinical supply facility.

For Catalent, the facility represents a key strategic hub in its Asia-Pacific network and global clinical supply business, supporting multinational customers’ growing needs for full clinical supply services, while providing flexible solutions for local customers in the Asia-Pacific region. The new expansion provides additional GMP space for secondary packaging, doubles ambient storage, and quadruples cold storage capacity at the site.

The site has seen significant growth since opening in 1998, almost tripling in size and now standing at almost 20,000 sq ft, with headcount also tripling since 2012.

With facilities in the U.S., U.K., Germany, Japan and China, and an extended network of more than 50 audited depots, Catalent’s clinical supply services business can handle a range of international compliance and distribution requirements to expedite clinical trials and ensure that customers are supplied where and when needed around the globe.

Companies in this article
More in Home